The Biotech Job Board
Built by Scientists
for Scientists

Where Science Careers Launch
500
companies
51,918
Jobs
ViaCyte
ViaCyte

ViaCyte is a privately held regenerative medicine company developing novel cell replacement therapies as potential long-term diabetes treatments to achieve glucose control targets and reduce the risk of hypoglycemia and diabetes-related complications. ViaCyte’s product candidates are based on directed differentiation of pluripotent stem cells into PEC-01 pancreatic islet progenitor cells, which are then implanted in durable and retrievable cell delivery devices. ViaCyte demonstrated that when effectively engrafted, PEC-01 cells can mature into glucose-responsive insulin producing cells in patients with type 1 diabetes. To accelerate and expand its efforts, ViaCyte has established collaborative partnerships with leading companies including CRISPR Therapeutics and W.L. Gore & Associates.
San Diego, CA, USA
viacyte.com
Inaccurate data? Flag it here.
Open jobs at ViaCyte
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.